IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 190 filers reported holding IMPAX LABORATORIES INC in Q1 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $38,501,000 | +24.3% | 1,979,464 | +6.4% | 0.65% | +22.9% |
| Q4 2017 | $30,968,000 | +103.0% | 1,859,924 | +147.5% | 0.53% | +108.3% |
| Q3 2017 | $15,257,000 | +25.5% | 751,576 | -0.4% | 0.25% | +21.0% |
| Q2 2017 | $12,153,000 | +23.6% | 754,865 | -2.9% | 0.21% | +13.5% |
| Q1 2017 | $9,830,000 | -1.6% | 777,095 | +3.1% | 0.18% | -4.6% |
| Q4 2016 | $9,990,000 | -53.2% | 753,953 | -16.3% | 0.19% | -51.6% |
| Q3 2016 | $21,340,000 | -19.3% | 900,433 | -1.8% | 0.40% | -26.6% |
| Q2 2016 | $26,437,000 | +6.7% | 917,323 | +18.5% | 0.55% | -0.5% |
| Q1 2016 | $24,783,000 | +1179.5% | 773,973 | +1608.7% | 0.55% | +1120.0% |
| Q4 2015 | $1,937,000 | +25.2% | 45,295 | +3.1% | 0.04% | +21.6% |
| Q3 2015 | $1,547,000 | +0.8% | 43,945 | +31.5% | 0.04% | +5.7% |
| Q2 2015 | $1,535,000 | -4.0% | 33,420 | -2.0% | 0.04% | -2.8% |
| Q1 2015 | $1,599,000 | – | 34,115 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 560,400 | $9,022,000 | 3.93% |
| NORTH TIDE CAPITAL, LLC | 1,000,000 | $16,100,000 | 3.58% |
| Sivik Global Healthcare LLC | 250,000 | $4,025,000 | 1.47% |
| MAVERICK CAPITAL LTD | 7,159,336 | $115,265,000 | 1.44% |
| SECTOR GAMMA AS | 589,311 | $9,488,000 | 1.38% |
| BRIDGER MANAGEMENT, LLC | 1,341,143 | $21,592,000 | 1.23% |
| Eos Focused Equity Management, L.P. | 48,714 | $784,000 | 0.89% |
| Bridge City Capital, LLC | 47,194 | $760,000 | 0.64% |
| Fosun International Ltd | 300,000 | $4,830,000 | 0.60% |
| Century Capital Management, LLC | 203,138 | $3,271,000 | 0.56% |